Explore Now NEW DELHI: The spectacular rally witnessed on Dalal Street since the March lows seems to have hit the bumps amid weak global cues and valuation concerns. Despite these frequent setbacks, one scrip has defied gravity and soared over 6,100 per cent in just four months. Analysts are comparing this stellar run with the surge that Ruchi Soya shares saw after Baba Ramdev’s Patanjali Group acquired the company last year in a bankruptcy sale. The stock is Orchid Pharma, which was relisted on November 3, 2020 at Rs 18 and has since surged 6,160 per cent to trade at Rs 1,129 on March 5, 2021. The scrip is hitting upper circuits ever since it got relisted.